logo conference-reports

Conference Reports

При финансовой поддержке logo MSD Oncology

ESMO 2018 – Do males and females with oesophagogastric cancer experience chemotherapy efficacy or toxicity differently?

A pooled analysis evaluated first-line chemotherapy regimens for patients with advanced OG cancer. Women were found to have experienced significantly higher rates of side effects.